Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
23 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Dr. Lindita Mustaka, Ophtalmologie from Wavre, company number BE0556980037, closed financial year 2025 with a result of € 532,585 after tax. For that financial year Dr. Lindita Mustaka, Ophtalmologie recorded a gross margin of € 740,515 and equity of € 20,460. Compared with financial year 2024, the result moved from € 404,629 to € 532,585. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 1, 2025.
€ 20,460
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 532,585
▲ 32% vs 2024
Profit after tax over the fiscal year.
€ 619,180
▲ 35% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 533,606 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 75,184
▼ 23% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 75,041
▼ 21% vs 2024
€ 20,059 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 1,144
▲ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 60,959
▲ 90% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 433,165 | € 503,933 | € 560,820 | € 740,515 | ▲ 32% |
| Profit after taxes | € 305,985 | € 357,659 | € 404,629 | € 532,585 | ▲ 32% |
| Equity | € 21,193 | € 20,852 | € 21,480 | € 20,460 | ▼ 5% |
| Total debts | € 356,638 | € 416,478 | € 543,081 | € 677,484 | ▲ 25% |
| Cash | € 337,949 | € 415,715 | € 457,270 | € 619,180 | ▲ 35% |
| Retained profit | € 2,593 | € 2,252 | € 2,880 | € 1,860 | ▼ 35% |
| Dividend | € 306,000 | € 358,000 | € 404,000 | € 533,606 | ▲ 32% |
| Bank debt | € 31,768 | € 35,141 | € 94,451 | € 75,041 | ▼ 21% |
| Balance sheet total | € 377,831 | € 437,329 | € 564,561 | € 697,944 | ▲ 24% |
Key figures of Dr. Lindita Mustaka, Ophtalmologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Dr. Lindita Mustaka, Ophtalmologie?
What happened at Dr. Lindita Mustaka, Ophtalmologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 532,585 (▲ 32% vs 2024). Source: NBB ↗
- New establishment in Wavre. KBO
- Lindita MUSTAKA became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 305,985 profit in 2022 to € 532,585 profit in 2025.
Paid € 530,421 in corporate taxes since 2022.
Best year ever: 2025, with € 532,585 profit.
Paid out € 1.6 million in dividends to the owners in total.
A new publication or filing at Dr. Lindita Mustaka, Ophtalmologie? We notify you, reason included.
Follow Dr. Lindita Mustaka, OphtalmologieDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Lindita Mustaka, Ophtalmologie is Lindita MUSTAKA.
Directors
According to the 2025 annual accounts
Lindita MUSTAKA
Director
since 2014
Establishments
Establishment units
Physical locations of this company
Avenue Pasteur 2 box B
1300 Wavre
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 23 companies are registered at this address.
All companies at this address →VAQUAFERRA
€ -58,200 gross margin · 2021
BENU
€ 172.2 million revenue · 2026
M.D.D. PHARMA
€ 28.6 million revenue · 2026
CENTRE RX DE WAVRE
€ 557,316 gross margin · 2025
IMMO X
€ 119,688 gross margin · 2025
+18 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
OVH Mail
Hosting
OVH, FR
DNS
OVH DNS
Website info
Features
Security
Network
Details
- Company number
- 0556.980.037
- VAT number
- BE 0556.980.037
- Registered office
- Avenue Pasteur 2 bus B, 1300 Wavre
- Names & denominations
- Dr. Lindita Mustaka, Ophtalmologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 July 2014
- Peppol
- Active · Active since 27 Nov 2024
- Contact
- 2bclinic.be
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van gespecialiseerde ziekenhuizen